Poly Medicure Ltd — Profit & Loss Statement

₹1191.10

-5.57%

Poly Medicure Ltd Profit & Loss Statement (Annual)

Metric	2025	2024	2023	2022	2021
Pretax Income	452.52 Cr	344.27 Cr	237.49 Cr	195.24 Cr	—
Tax Effect Of Unusual Items	0.00	0.00	-1.00 Cr	2.39 Cr	—
Tax Rate For Calcs	0.25	0.25	0.25	0.25	—
Normalized EBITDA	547.69 Cr	419.50 Cr	307.25 Cr	243.45 Cr	—
Total Unusual Items	0.00	0.00	-4.05 Cr	9.47 Cr	—
Total Unusual Items Excluding Goodwill	0.00	0.00	-4.05 Cr	9.47 Cr	—
Net Income From Continuing Operation Net Minority Interest	338.56 Cr	258.26 Cr	179.28 Cr	146.51 Cr	—
Reconciled Depreciation	83.18 Cr	63.93 Cr	57.17 Cr	53.95 Cr	—
Reconciled Cost Of Revenue	554.69 Cr	482.61 Cr	509.32 Cr	433.23 Cr	—
EBITDA	547.69 Cr	419.50 Cr	303.20 Cr	252.92 Cr	—
EBIT	464.51 Cr	355.57 Cr	246.03 Cr	198.97 Cr	—
Net Interest Income	-12.00 Cr	-11.30 Cr	-4.88 Cr	-3.87 Cr	—
Interest Expense	12.00 Cr	11.30 Cr	8.54 Cr	3.72 Cr	—
Normalized Income	338.56 Cr	258.26 Cr	182.33 Cr	139.43 Cr	—
Net Income From Continuing And Discontinued Operation	338.56 Cr	258.26 Cr	179.28 Cr	146.51 Cr	—
Total Expenses	1.30K Cr	1.08K Cr	890.81 Cr	752.83 Cr	—
Diluted Average Shares	9.93 Cr	9.60 Cr	9.60 Cr	9.60 Cr	—
Basic Average Shares	9.92 Cr	9.59 Cr	9.59 Cr	9.59 Cr	—
Diluted EPS	34.11	26.90	18.67	15.27	—
Basic EPS	34.13	26.92	18.69	15.28	—
Diluted NI Availto Com Stockholders	338.56 Cr	258.26 Cr	179.28 Cr	146.51 Cr	—
Net Income Common Stockholders	338.56 Cr	258.26 Cr	179.28 Cr	146.51 Cr	—
Otherunder Preferred Stock Dividend	0.00	0.00	0.00	0.00	—
Net Income	338.56 Cr	258.26 Cr	179.28 Cr	146.51 Cr	—
Net Income Including Noncontrolling Interests	338.56 Cr	258.26 Cr	179.28 Cr	146.51 Cr	—
Net Income Continuous Operations	338.56 Cr	258.26 Cr	179.28 Cr	146.51 Cr	—
Tax Provision	113.96 Cr	86.01 Cr	58.21 Cr	48.74 Cr	—
Other Non Operating Income Expenses	89.13 Cr	58.75 Cr	3.30 Cr	3.65 Cr	—
Special Income Charges	0.00	0.00	-0.04 Cr	-0.13 Cr	—
Net Non Operating Interest Income Expense	-12.00 Cr	-11.30 Cr	-4.88 Cr	-3.87 Cr	—
Interest Expense Non Operating	12.00 Cr	11.30 Cr	8.54 Cr	3.72 Cr	—
Operating Income	370.20 Cr	294.30 Cr	217.85 Cr	164.05 Cr	—
Operating Expense	744.94 Cr	598.89 Cr	381.49 Cr	319.61 Cr	—
Other Operating Expenses	336.20 Cr	270.10 Cr	72.18 Cr	55.99 Cr	—
Depreciation And Amortization In Income Statement	82.64 Cr	63.44 Cr	57.17 Cr	53.95 Cr	—
Depreciation Income Statement	82.64 Cr	63.44 Cr	54.25 Cr	51.27 Cr	—
Research And Development	24.57 Cr	19.44 Cr	17.80 Cr	18.77 Cr	—
Gross Profit	1.12K Cr	893.19 Cr	599.34 Cr	483.66 Cr	—
Cost Of Revenue	554.69 Cr	482.61 Cr	509.32 Cr	433.23 Cr	—
Total Revenue	1.67K Cr	1.38K Cr	1.11K Cr	916.89 Cr	—
Operating Revenue	1.67K Cr	1.38K Cr	1.11K Cr	916.89 Cr	—
Amortization	—	3.49 Cr	2.92 Cr	2.68 Cr	2.50 Cr
Interest Income	—	11.84 Cr	5.97 Cr	2.29 Cr	3.37 Cr
Rent Expense Supplemental	—	2.23 Cr	1.93 Cr	2.24 Cr	2.22 Cr
Minority Interests	—	0.00	0.00	0.00	0.00
Other Special Charges	—	-0.62 Cr	-0.10 Cr	-0.53 Cr	-72000.00
Write Off	—	1.18 Cr	0.14 Cr	0.66 Cr	0.18 Cr
Total Other Finance Cost	—	2.86 Cr	2.31 Cr	2.44 Cr	2.90 Cr
Interest Income Non Operating	—	11.84 Cr	5.97 Cr	2.29 Cr	3.37 Cr
Selling General And Administration	—	47.32 Cr	38.09 Cr	32.24 Cr	29.46 Cr
Selling And Marketing Expense	—	26.37 Cr	20.51 Cr	15.08 Cr	12.63 Cr
General And Administrative Expense	—	20.96 Cr	17.57 Cr	17.16 Cr	16.83 Cr
Rent And Landing Fees	—	2.23 Cr	1.93 Cr	2.24 Cr	2.22 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Poly Medicure Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Medical Equipment & Supplies Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.